Forestall
发表于 2025-3-21 18:06:24
书目名称Biomarkers in Breast Cancer影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0187804<br><br> <br><br>书目名称Biomarkers in Breast Cancer影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0187804<br><br> <br><br>书目名称Biomarkers in Breast Cancer网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0187804<br><br> <br><br>书目名称Biomarkers in Breast Cancer网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0187804<br><br> <br><br>书目名称Biomarkers in Breast Cancer被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0187804<br><br> <br><br>书目名称Biomarkers in Breast Cancer被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0187804<br><br> <br><br>书目名称Biomarkers in Breast Cancer年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0187804<br><br> <br><br>书目名称Biomarkers in Breast Cancer年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0187804<br><br> <br><br>书目名称Biomarkers in Breast Cancer读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0187804<br><br> <br><br>书目名称Biomarkers in Breast Cancer读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0187804<br><br> <br><br>
nutrition
发表于 2025-3-21 22:25:44
http://reply.papertrans.cn/19/1879/187804/187804_2.png
PANG
发表于 2025-3-22 00:29:38
Urokinase-Type Plasminogen Activator and PAI-1 factors has the potential to result in the enhanced management of patients with breast cancer. Measurement of these analytes should thus be now considered for use in the routine management of patients with breast cancer.
培养
发表于 2025-3-22 07:22:27
Predictive Value of c-,B2 for Endocrine Therapy and Chemotherapy in Breast Cancer, other regimens should not be withheld from women who cannot receive an anthracyline. Current clinical data also suggest a possible sensitivity to taxane-based therapy, especially when combined with an anthracycline. Trastuzumab-based therapy should be considered as first line therapy for women wit
hemoglobin
发表于 2025-3-22 12:16:05
http://reply.papertrans.cn/19/1879/187804/187804_5.png
mastoid-bone
发表于 2025-3-22 13:41:19
http://reply.papertrans.cn/19/1879/187804/187804_6.png
sterilization
发表于 2025-3-22 17:55:07
Circulating Vascular Endothelial Growth Factore with each other due to a lack of standardization of the pre-analytical phase. The chapter presents the main studies concerning anti-VEGF therapies; several studies evaluated the safety profile and activity of the combination of standard chemotherapy with new antiangiogenic agents. However, to date
gusher
发表于 2025-3-23 01:04:53
http://reply.papertrans.cn/19/1879/187804/187804_8.png
条街道往前推
发表于 2025-3-23 02:56:16
http://reply.papertrans.cn/19/1879/187804/187804_9.png
OREX
发表于 2025-3-23 07:13:36
http://reply.papertrans.cn/19/1879/187804/187804_10.png